Discover how urinary microRNA biomarkers can non-invasively identify aggressive bladder cancer subtypes. Read more on this ...
No significant difference seen between patients with colorectal cancer and color vision deficiency versus those without color vision deficiency.
Urinary retention is a serious medical condition that affects millions of people worldwide and can lead to significant ...
Dr. Yaniv Larish told us what we should be feeling and seeing when we pee — and what may be a sign that it's time to visit a ...
ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that it recently held a Type B ...
ImmunityBio stock rose 19.8% after FDA meeting on ANKTIVA bladder cancer treatment. Company to submit additional data within ...
Following discussions with the U.S. FDA, the Agency recommended that the Company submit additional information for its evaluation of this information to potentially support a resubmission of the sBLA ...
Boston Scientific Corporation (NYSE:BSX) is included in our list of the best stocks to buy right now. On January 12, 2026, ...
Investing.com -- ImmunityBio Inc (NASDAQ:IBRX) stock surged 19.8% in premarket trading Tuesday after the company reported ...
Struggling with sudden bladder urgency, leaks, or accidents? This guide explains overactive bladder in medical terms, why it ...